A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection.
Saved in:
| Title: | A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection. |
|---|---|
| Authors: | Gerber PP; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Duncan LM; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Greenwood EJ; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Marelli S; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Naamati A; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Teixeira-Silva A; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Crozier TW; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Gabaev I; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Zhan JR; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Mulroney TE; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Horner EC; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Doffinger R; Department of Clinical Biochemistry and Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Willis AE; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Thaventhiran JE; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Protasio AV; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Matheson NJ; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.; NHS Blood and Transplant, Cambridge, United Kingdom. |
| Source: | PLoS pathogens [PLoS Pathog] 2022 Feb 10; Vol. 18 (2), pp. e1010265. Date of Electronic Publication: 2022 Feb 10 (Print Publication: 2022). |
| Publication Type: | Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35143592 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gerber+PP%22">Gerber PP</searchLink>; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Duncan+LM%22">Duncan LM</searchLink>; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Greenwood+EJ%22">Greenwood EJ</searchLink>; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Marelli+S%22">Marelli S</searchLink>; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Naamati+A%22">Naamati A</searchLink>; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Teixeira-Silva+A%22">Teixeira-Silva A</searchLink>; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Crozier+TW%22">Crozier TW</searchLink>; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gabaev+I%22">Gabaev I</searchLink>; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Zhan+JR%22">Zhan JR</searchLink>; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mulroney+TE%22">Mulroney TE</searchLink>; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Horner+EC%22">Horner EC</searchLink>; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Doffinger+R%22">Doffinger R</searchLink>; Department of Clinical Biochemistry and Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Willis+AE%22">Willis AE</searchLink>; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Thaventhiran+JE%22">Thaventhiran JE</searchLink>; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Protasio+AV%22">Protasio AV</searchLink>; Department of Pathology, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Matheson+NJ%22">Matheson NJ</searchLink>; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.; NHS Blood and Transplant, Cambridge, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2022 Feb 10; Vol. 18 (2), pp. e1010265. <i>Date of Electronic Publication: </i>2022 Feb 10 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35143592 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.ppat.1010265 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1010265 Titles: – TitleFull: A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gerber PP – PersonEntity: Name: NameFull: Duncan LM – PersonEntity: Name: NameFull: Greenwood EJ – PersonEntity: Name: NameFull: Marelli S – PersonEntity: Name: NameFull: Naamati A – PersonEntity: Name: NameFull: Teixeira-Silva A – PersonEntity: Name: NameFull: Crozier TW – PersonEntity: Name: NameFull: Gabaev I – PersonEntity: Name: NameFull: Zhan JR – PersonEntity: Name: NameFull: Mulroney TE – PersonEntity: Name: NameFull: Horner EC – PersonEntity: Name: NameFull: Doffinger R – PersonEntity: Name: NameFull: Willis AE – PersonEntity: Name: NameFull: Thaventhiran JE – PersonEntity: Name: NameFull: Protasio AV – PersonEntity: Name: NameFull: Matheson NJ IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 02 Text: 2022 Feb 10 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1553-7374 Numbering: – Type: volume Value: 18 – Type: issue Value: 2 Titles: – TitleFull: PLoS pathogens Type: main |
| ResultId | 1 |